- Investing Ideas
- /
- Canadian Pharmaceuticals & Biotech High Insider Buying
Canadian Pharmaceuticals & Biotech High Insider Buying
Results
24
Stocks with high levels of insider buying the past 3 months and good analyst coverage.
24 companies
Knight Therapeutics
Market Cap: CA$575.3m
Focuses on acquiring, in-licensing, out-licensing, marketing, and commercializing prescription pharmaceutical products in Canada and Latin America.
GUD
CA$5.91
7D
1.2%
1Y
8.2%
Eupraxia Pharmaceuticals
Market Cap: CA$555.6m
A clinical-stage biotechnology company, focuses on the development of products to address therapeutic areas with unmet medical need.
EPRX
CA$12.26
7D
-0.3%
1Y
176.1%
NervGen Pharma
Market Cap: CA$452.4m
A biotechnology company, engages in the discovery, development, and commercialization of pharmaceutical treatments to promote nervous system repair in settings of neurotrauma and neurologic disease.
NGEN
CA$5.79
7D
-7.4%
1Y
97.6%
Organigram Global
Market Cap: CA$276.8m
Engages in the production and sale of cannabis and cannabis-derived products in Canada.
OGI
CA$2.16
7D
-3.1%
1Y
0.9%
Grown Rogue International
Market Cap: CA$140.0m
A craft cannabis company, focuses on premium flower and flower-derived products.
GRIN
CA$0.55
7D
-1.8%
1Y
-38.9%
ME Therapeutics Holdings
Market Cap: CA$104.9m
A preclinical stage biotechnology company, engages in the development of cancer fighting drugs in the field of immuno-oncology.
METX
CA$3.50
7D
16.7%
1Y
-56.3%
Medexus Pharmaceuticals
Market Cap: CA$91.9m
Operates as a pharmaceutical company in Canada and the United States.
MDP
CA$2.85
7D
-2.7%
1Y
-25.0%
Medicenna Therapeutics
Market Cap: CA$75.1m
A clinical-stage immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer, inflammation, and immune-mediated diseases.
MDNA
CA$0.87
7D
-1.1%
1Y
-31.0%
LIR Life Sciences
Market Cap: CA$51.6m
Operates as biopharmaceutical company that develops transdermal delivery system for obesity and metabolic disorders.
SKNY
CA$1.82
7D
-11.2%
1Y
n/a
Sona Nanotech
Market Cap: CA$45.2m
Operates as a nanotechnology life sciences company.
SONA
CA$0.40
7D
-8.0%
1Y
48.1%
Microbix Biosystems
Market Cap: CA$30.5m
A life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally.
MBX
CA$0.22
7D
2.3%
1Y
-54.2%
Rubicon Organics
Market Cap: CA$29.9m
Engages in the production, processing, and sale of organic cannabis for the recreational and medical-use markets in Canada and internationally.
ROMJ
CA$0.45
7D
-3.3%
1Y
27.1%
Optimi Health
Market Cap: CA$29.4m
Operates as a GMP-certified pharmaceutical drug manufacturing company in Canada.
OPTI
CA$0.30
7D
-6.2%
1Y
48.8%
Simply Solventless Concentrates
Market Cap: CA$19.6m
Simply Solventless Concentrates Ltd. cultivates, processes, formulates, manufactures, and sells a portfolio of terpene-rich solventless concentrates for the recreational, medical, and business to business cannabis markets in Canada.
HASH
CA$0.17
7D
-10.5%
1Y
-76.7%
Hemostemix
Market Cap: CA$18.5m
A clinical stage biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions in Canada.
HEM
CA$0.09
7D
-5.3%
1Y
-69.0%
Cytophage Technologies
Market Cap: CA$10.5m
A biotechnology company, engages in the research, development, and commercialization bacteriophage therapies to treat bacterial infections affecting human health, animal health, and food security in Canada.
CYTO
CA$0.16
7D
0%
1Y
-33.3%
Glow Lifetech
Market Cap: CA$10.0m
A biotechnology company, focuses on producing nutraceutical and cannabinoid-based products.
GLOW
CA$0.055
7D
10.0%
1Y
-21.4%
Christina Lake Cannabis
Market Cap: CA$8.7m
A license cannabis producer, engages in the research and development, cultivation, processing, production, and sale of cannabis in Canada.
CLC
CA$0.035
7D
-12.5%
1Y
0%
BioVaxys Technology
Market Cap: CA$7.7m
A clinical-stage biotechnology company, engages in developing viral and oncology vaccine platforms and immuno-diagnostics.
BIOV
CA$0.17
7D
-18.6%
1Y
-70.8%
Marvel Biosciences
Market Cap: CA$7.5m
A biotechnology company, develops synthetic chemical derivatives of the original approved drug for the new disease indication in Canada.
MRVL
CA$0.14
7D
-3.6%
1Y
-12.9%
Blueberries Medical
Market Cap: CA$7.4m
Engages in the growth, cultivation, and development of medicinal cannabis and related products in Colombia.
BBM
CA$0.015
7D
-25.0%
1Y
0%
Kane Biotech
Market Cap: CA$7.3m
A biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally.
KNE
CA$0.04
7D
0%
1Y
-61.9%
City View Green Holdings
Market Cap: CA$2.7m
A consumer-packaged goods company, formulates, produces, and sells cannabis edibles and related products in Canada.
CVGR
CA$0.045
7D
-25.0%
1Y
-70.0%
Algernon Health
Market Cap: CA$2.4m
Operates as a clinical stage pharmaceutical development company in Canada and Australia.
AGN
CA$0.05
7D
0%
1Y
-37.5%